Progressive neurodegeneration following spinal cord injury
Implications for clinical trials
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective To quantify atrophy, demyelination, and iron accumulation over 2 years following acute spinal cord injury and to identify MRI predictors of clinical outcomes and determine their suitability as surrogate markers of therapeutic intervention.
Methods We assessed 156 quantitative MRI datasets from 15 patients with spinal cord injury and 18 controls at baseline and 2, 6, 12, and 24 months after injury. Clinical recovery (including neuropathic pain) was assessed at each time point. Between-group differences in linear and nonlinear trajectories of volume, myelin, and iron change were estimated. Structural changes by 6 months were used to predict clinical outcomes at 2 years.
Results The majority of patients showed clinical improvement with recovery stabilizing at 2 years. Cord atrophy decelerated, while cortical white and gray matter atrophy progressed over 2 years. Myelin content in the spinal cord and cortex decreased progressively over time, while cerebellar loss decreases decelerated. As atrophy progressed in the thalamus, sustained iron accumulation was evident. Smaller cord and cranial corticospinal tract atrophy, and myelin changes within the sensorimotor cortices, by 6 months predicted recovery in lower extremity motor score at 2 years. Whereas greater cord atrophy and microstructural changes in the cerebellum, anterior cingulate cortex, and secondary sensory cortex by 6 months predicted worse sensory impairment and greater neuropathic pain intensity at 2 years.
Conclusion These results draw attention to trauma-induced neuroplastic processes and highlight the intimate relationships among neurodegenerative processes in the cord and brain. These measurable changes are sufficiently large, systematic, and predictive to render them viable outcome measures for clinical trials.
Glossary
- ACC=
- anterior cingulate cortex;
- AIS=
- American Spinal Injury Association Impairment Scale;
- APW=
- anterior-posterior width;
- CI=
- confidence interval;
- CST=
- corticospinal tract;
- GM=
- gray matter;
- LRW=
- cord left-right width;
- M1=
- primary motor cortices;
- MT=
- magnetization transfer saturation;
- R2*=
- effective transverse relaxation rate;
- ROI=
- region of interest;
- S2=
- secondary sensory cortices;
- SCI=
- spinal cord injury;
- SCIM=
- Spinal Cord Independence Measure;
- SPM=
- statistical parametric mapping;
- WM=
- white matter
Footnotes
↵* These authors contributed equally to this work as first authors.
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
The Article Processing Charge was funded by Wellcome Trust.
- Received July 14, 2017.
- Accepted in final form January 4, 2018.
- Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Disputes & Debates: Rapid online correspondence
- Author response to Dr. Domingue
- Patrick Freund, Neuroscientist and Neurologist Trainee, University of Zürich
- Alan Thompson, Neurologist and Dean of Brain Science, University College London
- Armin Curt, Neurologist and Director of SCI Centre Balgrist, University of Zürich
- Markus Hupp, Neurologist, University of Zürich
- Nikolaus Weiskopf, Physicist and Director of Neurophysics Department, MPI Leipzig
- Patrick Grabher, Neuroscientist, University of Zürich
- Daniel Altmann, Scientist, Medical Statistics Department, London School of Hygiene & Tropical Medicine
- Karl Friston, Scientific Director, Wellcome Trust Centre for Neuroimaging, University College London
- John Ashburner, Neuroscientist, Wellcome Trust Centre for Neuroimaging, University College London
- Gabriel Ziegler, Neuroscientist, German Center for Neurodegenerative Diseases
Submitted June 21, 2018 - Reader response: Progressive neurodegeneration following spinal cord injury
- James Domingue, Neurologist, Private practice (Lafayette, LA)
Submitted April 19, 2018
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.